NMR Standards
Proteins
MMP2 - hemopexin like domain
Human, recombinant
Residues 467-660, UniProtKB accession P08253
MW = 22.4 kDa
EC # 3.4.24.24
CAT # G04MP02H
MMP20 - catalytic domain
Human, recombinant
Residues 113-271, UniProtKB accession O60882
MW = 17.5 kDa
EC # 3.4.24.-
CAT # G04MP20C
MMP3 - catalytic domain
Human, recombinant
Residues 100-272, UniProtKB accession P08254
MW = 19.5 kDa
EC # 3.4.24.17
CAT # G04MP03C
MMP3 - catalytic domain, inactive mutant
Human, recombinant
Residues 100-272, UniProtKB accession P08254
MW = 19.5 kDa
EC # 3.4.24.17
CAT # G04MP03Ci
MMP3 - catalytic domain, mutant with improved stability
Human, recombinant.
Residues 100-272, UniProtKB accession P08254
MW = 19.5 kDa.
EC # 3.4.24.17
CAT # G04MP03Cm
MMP7 - catalytic domain
Human, recombinant
Residues 95-267, UniProtKB accession P09237
MW = 19.3 kDa
EC # 3.4.24.23
CAT # G04MP07C
MMP8 - catalytic domain
Human, recombinant
Residues 105-262, UniProtKB accession P22894
MW = 17.6 kDa
EC # 3.4.24.34
CAT # G04MP08C
MMP9 - catalytic domain
Human, recombinant
Residues 112-445, UniProtKB accession P14780
MW = 37.7 kDa
EC # 3.4.24.35
CAT # G04MP09C
NSP1
from SARS-CoV-2, recombinant
alternative name: leader protein
Residues 1-180, NCBI reference sequence YP_009725297.1
MW = 19.8 kDa
CAT # G19NP011
NSP10
from SARS-CoV-2, recombinant
alternative name: growth-factor-like protein, GFL
Residues 1-139, NCBI reference sequence YP_009725306.1
MW = 14.8 kDa
CAT # G19NP101
NSP14
from SARS-CoV-2, recombinant
alternative name: 3'-to-5' exonuclease
Residues 1-527, NCBI reference sequence YP_009725309.1
MW = 59.8 kDa
CAT # G19NP141
NSP15
from SARS-CoV-2, recombinant
alternative name: endoRNAse
Residues 1-346, NCBI reference sequence YP_009725310.1
MW = 38.8 kDa
CAT # G19NP151
NSP16
from SARS-CoV-2, recombinant
alternative name: 2'-O-ribose methyltransferase
Residues 1-298, NCBI reference sequence YP_009725311.1
MW = 33.3 kDa
CAT # G19NP161
NSP3, ADP ribose phosphatase domain
from SARS-CoV-2, recombinant
alternative name: ADP ribose phosphatase, nsp3 macro x domain
Residues 206-426, NCBI reference sequence YP_009725299.1
MW = 25.4 kDa
CAT # G19NP031
NSP3, papain-like proteinase domain
from SARS-CoV-2, recombinant
alternative name: papain-like proteinase, nsp3d, Plpro
Residues 746-1060, NCBI reference sequence YP_009725299.1
MW = 36.8 kDa
CAT # G19NP03P1
NSP4, C-terminal cytoplasmic domain
from SARS-CoV-2, recombinant
alternative name: C-terminal cytoplasmic domain of nsp4
Residues 406-500, NCBI reference sequence YP_009742611.1
MW = 10.7 kDa
CAT # G19NP041
NSP5
from SARS-CoV-2, recombinant
alternative name: main protease, 3CLp, 3CL-PRO, 3C-like proteinase
Residues 1-306, NCBI reference sequence YP_009725301.1
MW = 34.2 kDa
CAT # G19NP051
NSP7
from SARS-CoV-2, recombinant
Residues 1-83, NCBI reference sequence YP_009725303.1
MW = 9.2 kDa
CAT # G19NP071
NSP8
from SARS-CoV-2, recombinant
Residues 1-198, NCBI reference sequence YP_009725304.1
MW = 21.9 kDa
CAT # G19NP081
Proteins
MMP2 - hemopexin like domain
Human, recombinant
Residues 467-660, UniProtKB accession P08253
MW = 22.4 kDa
EC # 3.4.24.24
CAT # G04MP02H
MMP20 - catalytic domain
Human, recombinant
Residues 113-271, UniProtKB accession O60882
MW = 17.5 kDa
EC # 3.4.24.-
CAT # G04MP20C
MMP3 - catalytic domain
Human, recombinant
Residues 100-272, UniProtKB accession P08254
MW = 19.5 kDa
EC # 3.4.24.17
CAT # G04MP03C
MMP3 - catalytic domain, inactive mutant
Human, recombinant
Residues 100-272, UniProtKB accession P08254
MW = 19.5 kDa
EC # 3.4.24.17
CAT # G04MP03Ci
MMP3 - catalytic domain, mutant with improved stability
Human, recombinant.
Residues 100-272, UniProtKB accession P08254
MW = 19.5 kDa.
EC # 3.4.24.17
CAT # G04MP03Cm
MMP7 - catalytic domain
Human, recombinant
Residues 95-267, UniProtKB accession P09237
MW = 19.3 kDa
EC # 3.4.24.23
CAT # G04MP07C
MMP8 - catalytic domain
Human, recombinant
Residues 105-262, UniProtKB accession P22894
MW = 17.6 kDa
EC # 3.4.24.34
CAT # G04MP08C
MMP9 - catalytic domain
Human, recombinant
Residues 112-445, UniProtKB accession P14780
MW = 37.7 kDa
EC # 3.4.24.35
CAT # G04MP09C
NSP1
from SARS-CoV-2, recombinant
alternative name: leader protein
Residues 1-180, NCBI reference sequence YP_009725297.1
MW = 19.8 kDa
CAT # G19NP011
NSP10
from SARS-CoV-2, recombinant
alternative name: growth-factor-like protein, GFL
Residues 1-139, NCBI reference sequence YP_009725306.1
MW = 14.8 kDa
CAT # G19NP101
NSP14
from SARS-CoV-2, recombinant
alternative name: 3'-to-5' exonuclease
Residues 1-527, NCBI reference sequence YP_009725309.1
MW = 59.8 kDa
CAT # G19NP141
NSP15
from SARS-CoV-2, recombinant
alternative name: endoRNAse
Residues 1-346, NCBI reference sequence YP_009725310.1
MW = 38.8 kDa
CAT # G19NP151
NSP16
from SARS-CoV-2, recombinant
alternative name: 2'-O-ribose methyltransferase
Residues 1-298, NCBI reference sequence YP_009725311.1
MW = 33.3 kDa
CAT # G19NP161
NSP3, ADP ribose phosphatase domain
from SARS-CoV-2, recombinant
alternative name: ADP ribose phosphatase, nsp3 macro x domain
Residues 206-426, NCBI reference sequence YP_009725299.1
MW = 25.4 kDa
CAT # G19NP031
NSP3, papain-like proteinase domain
from SARS-CoV-2, recombinant
alternative name: papain-like proteinase, nsp3d, Plpro
Residues 746-1060, NCBI reference sequence YP_009725299.1
MW = 36.8 kDa
CAT # G19NP03P1
NSP4, C-terminal cytoplasmic domain
from SARS-CoV-2, recombinant
alternative name: C-terminal cytoplasmic domain of nsp4
Residues 406-500, NCBI reference sequence YP_009742611.1
MW = 10.7 kDa
CAT # G19NP041
NSP5
from SARS-CoV-2, recombinant
alternative name: main protease, 3CLp, 3CL-PRO, 3C-like proteinase
Residues 1-306, NCBI reference sequence YP_009725301.1
MW = 34.2 kDa
CAT # G19NP051
NSP7
from SARS-CoV-2, recombinant
Residues 1-83, NCBI reference sequence YP_009725303.1
MW = 9.2 kDa
CAT # G19NP071
NSP8
from SARS-CoV-2, recombinant
Residues 1-198, NCBI reference sequence YP_009725304.1
MW = 21.9 kDa
CAT # G19NP081